← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

▼ SELL 10b5-1 Plan

$ Value

$437K

Shares

15,211

Price

$29

Filed

Jun 5

Insider

Name

Megna Michael R

Title

CHIEF ACCOUNTING OFFICER

CIK

0001464583

Roles

Officer

Transaction Details

Transaction Date

2025-06-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,546

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $28.75 and $28.755. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001415889-25-015782

Form Type

4

Issuer CIK

0001730430

Megna Michael R's History

Date Ticker Type Value
2026-04-09 KNSA $309K
2026-04-07 KNSA M $4K
2026-04-07 KNSA F $82K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $154K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $1.1M 2026-04-06
Levy Richard S 2026-02-01
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07